Jennifer Foglietta

Clinical outcome of patients with brain metastases from HER2-positive breast cancer treated with lapatinib and capecitabine

Giulio Metro, Jennifer Foglietta, Michelangelo Russillo et al. · Annals of Oncology · 2010 · 168 citations

Medicine, Oncology, Breast Oncology +15

EGFR, pMAPK, pAkt and PTEN status by immunohistochemistry: correlation with clinical outcome in HER2-positive metastatic breast cancer patients treated with trastuzumab

Stefania Gori, Angelo Sidoni, Mariantonietta Colozza et al. · Annals of Oncology · 2009 · 73 citations

Medicine, Cancer Biology, Oncology +16

A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study

Teresa Gamucci, Laura Pizzuti, Clara Natoli et al. · Cancer Biology & Therapy · 2018 · 42 citations · Full text

Medicine, Pharmacology, Cancer Pharmacology +15

Retreatment with trastuzumab-based therapy after disease progression following lapatinib in HER2-positive metastatic breast cancer

Stefania Gori, Filippo Montemurro, Simon Spazzapan et al. · Annals of Oncology · 2011 · 41 citations · Full text

Medicine, Oncology, Pharmacology +16

Phase II study of eribulin in combination with gemcitabine for the treatment of patients with locally advanced or metastatic triple negative breast cancer (ERIGE trial). Clinical and pharmacogenetic results on behalf of the Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC)

Benedetta Pellegrino, Luigi Cavanna, Daniela Boggiani et al. · ESMO Open · 2021 · 24 citations · Full text

Medicine, Oncology, Pharmacology +17